Artia Global Partners’s Eli Lilly LLY Stock Holding History

Artia Global Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,000	Closed	-$37.2M	–	41
2025 Q1	$37.2M	Buy	+45,000	New	+$37.4M	9.41%	2
2024 Q4	–	Sell	-15,000	Closed	-$13.3M	–	49
2024 Q3	$13.3M	Sell	15,000 -60,000	-80%	-$53.9M	3.62%	7
2024 Q2	$67.9M	Sell	75,000 -40,000	-35%	-$32M	13.13%	3
2024 Q1	$89.5M	Buy	115,000 +75,000	+188%	+$53.4M	17.98%	1
2023 Q4	$23.3M	Buy	+40,000	New	+$23.3M	6.78%	6

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artia Global Partners's LLY Position: Q1 2026 in Review

Artia Global Partners reduced its Eli Lilly (LLY) stake by 24% in Q1 2026, selling an estimated $12.4M and leaving 38,220 shares worth $35.2M. The position accounts for 7.04% of the portfolio, ranked #4.

Artia Global Partners first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. The position peaked at $83.8M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Artia Global Partners held 38,220 shares of Eli Lilly worth $35.2M as of Q1 2026.
Artia Global Partners sold 12,280 Eli Lilly shares in Q1 2026, an estimated $12.4M.
Eli Lilly made up 7.04% of Artia Global Partners's portfolio in Q1 2026, its #4 holding.
Artia Global Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
Artia Global Partners's Eli Lilly position peaked at $83.8M in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.